Quetiapine and repetitive transcranial magnetic stimulation ameliorate depression-like behaviors and up-regulate the proliferation of hippocampal-derived neural stem cells in a rat model of depression: The involvement of the BDNF/ERK signal pathway

Pharmacology Biochemistry and Behavior

Volumn 136, Issue , 2015, Pages 39-46

  Chen, Yi Huan ^a   Zhang, Rui Guo ^a   Xue, Fen ^a   Wang, Hua Ning ^a   Chen, Yun Chun ^a   Hu, Guang Tao ^b   Peng, Ye ^c   Peng, Zheng Wu ^a   Tan, Qing Rong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b SHANDONG MENTAL HEALTH CENTER   (China)

^c AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

BDNF ERK; CUS; NSCs; Quetiapine; rTMS

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; BRAIN DERIVED NEUROTROPHIC FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; QUETIAPINE; 1,3 BUTADIENE DERIVATIVE; ANTIDEPRESSANT AGENT; NITRILE;

ADULT; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CHRONIC UNPREDICTABLE STRESS; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; FORCED SWIM TEST; HIPPOCAMPUS; IMMOBILITY; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; NEURAL STEM CELL; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SUCROSE PREFERENCE TEST; TRANSCRANIAL MAGNETIC STIMULATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

RATTUS;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; BUTADIENES; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DEPRESSION; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MALE; MAP KINASE SIGNALING SYSTEM; NEURAL STEM CELLS; NITRILES; QUETIAPINE FUMARATE; RATS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84936989949     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2015.07.005     Document Type: Article

References (56)

1. F.R. Bambico, N.T. Nguyen, and G. Gobbi Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress Eur. Neuropsychopharmacol. 19 2009 215 228
2. M.T. Berlim, A. McGirr, M.M. Beaulieu, and G. Turecki High frequency repetitive transcranial magnetic stimulation as an augmenting strategy in severe treatment-resistant major depression: a prospective 4-week naturalistic trial J. Affect. Disord. 130 2011 312 317
3. J.A. Blendy The role of CREB in depression and antidepressant treatment Biol. Psychiatry 59 2006 1144 1150
4. L. Bocchio-Chiavetto, C. Miniussi, R. Zanardini, A. Gazzoli, S. Bignotti, C. Specchia, and et al. 5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression Neurosci. Lett. 437 2008 130 134
5. B. Chen, D. Dowlatshahi, G.M. MacQueen, J.F. Wang, and L.T. Young Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication Biol. Psychiatry 50 2001 260 265
6. A.C. Conti, and J.A. Blendy Regulation of antidepressant activity by cAMP response element binding proteins Mol. Neurobiol. 30 2004 143 155
7. J.L. Couturier Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis J. Psychiatry Neurosci. 30 2005 83 90
8. B. Cuccurazzu, L. Leone, M.V. Podda, R. Piacentini, E. Riccardi, C. Ripoli, and et al. Exposure to extremely low-frequency (50 Hz) electromagnetic fields enhances adult hippocampal neurogenesis in C57BL/6 mice Exp. Neurol. 226 2010 173 182
9. B. Di Benedetto, R. Kuhn, C. Nothdurfter, T. Rein, W. Wurst, and R. Rupprecht N-desalkylquetiapine activates ERK1/2 to induce GDNF release in C6 glioma cells: a putative cellular mechanism for quetiapine as antidepressant Neuropharmacology 62 2012 209 216
10. A.E. Donaldson, M.S. Gordon, G.A. Melvin, D.A. Barton, and P.B. Fitzgerald Addressing the needs of adolescents with treatment resistant depressive disorders: a systematic review of rTMS Brain Stimul. 7 2014 7 12
11. C.H. Duman, L. Schlesinger, M. Kodama, D.S. Russell, and R.S. Duman A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment Biol. Psychiatry 61 2007 661 670
12. L.E. Duncan, K.E. Hutchison, G. Carey, and W.E. Craighead Variation in brain-derived neurotrophic factor (BDNF) gene is associated with symptoms of depression J. Affect. Disord. 115 2009 215 219
13. Y. Dwivedi, H.S. Rizavi, R.C. Roberts, R.C. Conley, C.A. Tamminga, and G.N. Pandey Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects J. Neurochem. 77 2001 916 928
14. J. Endicott, B. Paulsson, U. Gustafsson, H. Schioler, and M. Hassan Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: improvements in quality of life and quality of sleep J. Affect. Disord. 111 2008 306 319
15. S.K. Esser, R. Huber, M. Massimini, M.J. Peterson, F. Ferrarelli, and G. Tononi A direct demonstration of cortical LTP in humans: a combined TMS/EEG study Brain Res. Bull. 69 2006 86 94
16. S.F. Feng, T.Y. Shi, Y. Fan, W.N. Wang, Y.C. Chen, and Q.R. Tan Long-lasting effects of chronic rTMS to treat chronic rodent model of depression Behav. Brain Res. 232 2012 245 251
17. B.N. Gaynes, S.W. Lloyd, L. Lux, G. Gartlehner, R.A. Hansen, S. Brode, and et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis J. Clin. Psychiatry 75 2014 477 489 (quiz 89)
18. S. Grehl, H.M. Viola, P.I. Fuller-Carter, K.W. Carter, S.A. Dunlop, L.C. Hool, and et al. Cellular and molecular changes to cortical neurons following low intensity repetitive magnetic stimulation at different frequencies Brain Stimul. 8 2015 114 123
19. J.O. Groves Is it time to reassess the BDNF hypothesis of depression? Mol. Psychiatry 12 2007 1079 1088
20. F. Guo, X. Han, J. Zhang, X. Zhao, J. Lou, H. Chen, and et al. Repetitive transcranial magnetic stimulation promotes neural stem cell proliferation via the regulation of MiR-25 in a rat model of focal cerebral ischemia PLoS One 9 2014 e109267
21. G.A. Hargreaves, I.S. McGregor, and P.S. Sachdev Chronic repetitive transcranial magnetic stimulation is antidepressant but not anxiolytic in rat models of anxiety and depression Psychiatry Res. 137 2005 113 121
22. L.L. Hurley, L. Akinfiresoye, E. Nwulia, A. Kamiya, A.A. Kulkarni, and Y. Tizabi Antidepressant-like effects of curcumin in WKY rat model of depression is associated with an increase in hippocampal BDNF Behav. Brain Res. 239 2013 27 30
23. B.L. Jacobs, H. van Praag, and F.H. Gage Adult brain neurogenesis and psychiatry: a novel theory of depression Mol. Psychiatry 5 2000 262 269
24. M.N. Jayatissa, K. Henningsen, M.J. West, and O. Wiborg Decreased cell proliferation in the dentate gyrus does not associate with development of anhedonic-like symptoms in rats Brain Res. 1290 2009 133 141
25. Y.F. Li, Y.Z. Zhang, Y.Q. Liu, H.L. Wang, L. Yuan, and Z.P. Luo Moclobemide up-regulates proliferation of hippocampal progenitor cells in chronically stressed mice Acta Pharmacol. Sin. 25 2004 1408 1412
26. C. Luo, H. Xu, and X.M. Li Quetiapine reverses the suppression of hippocampal neurogenesis caused by repeated restraint stress Brain Res. 1063 2005 32 39
27. J. Ma, Z. Zhang, Y. Su, L. Kang, D. Geng, Y. Wang, and et al. Magnetic stimulation modulates structural synaptic plasticity and regulates BDNF-TrkB signal pathway in cultured hippocampal neurons Neurochem. Int. 62 2013 84 91
28. G.M. MacQueen, S. Campbell, B.S. McEwen, K. Macdonald, S. Amano, R.T. Joffe, and et al. Course of illness, hippocampal function, and hippocampal volume in major depression Proc. Natl. Acad. Sci. U. S. A. 100 2003 1387 1392
29. I. Mahar, F.R. Bambico, N. Mechawar, and J.N. Nobrega Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects Neurosci. Biobehav. Rev. 38 2014 173 192
30. J.E. Malberg, A.J. Eisch, E.J. Nestler, and R.S. Duman Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus J. Neurosci. 20 2000 9104 9110
31. M. Massouh, and A. Saghatelyan De-routing neuronal precursors in the adult brain to sites of injury: role of the vasculature Neuropharmacology 58 2010 877 883
32. C.D. Mathers, and D. Loncar Projections of global mortality and burden of disease from 2002 to 2030 PLoS Med. 3 2006 e442
33. S.J. Mathew, H.K. Manji, and D.S. Charney Novel drugs and therapeutic targets for severe mood disorders Neuropsychopharmacology 33 2008 2080 2092
34. F. Matrisciano, M. Zusso, I. Panaccione, B. Turriziani, A. Caruso, L. Iacovelli, and et al. Synergism between fluoxetine and the mGlu2/3 receptor agonist, LY379268, in an in vitro model for antidepressant drug-induced neurogenesis Neuropharmacology 54 2008 428 437
35. Y.S. Mineur, C. Belzung, and W.E. Crusio Functional implications of decreases in neurogenesis following chronic mild stress in mice Neuroscience 150 2007 251 259
36. C.U. Pae, M.S. Sohi, H.J. Seo, A. Serretti, A.A. Patkar, D.C. Steffens, and et al. Quetiapine XR: current status for the treatment of major depressive disorder Prog. Neuro-Psychopharmacol. Biol. Psychiatry 34 2010 1165 1173
37. C.D. Pandya, A. Kutiyanawalla, and A. Pillai BDNF-TrkB signaling and neuroprotection in schizophrenia Asian J. Psychiatry 6 2013 22 28
38. L.H. Pao, S.W. Lu, G.G. Sun, S.H. Chiou, and K.H. Ma Three Chinese herbal medicines promote neuroproliferation in vitro, and reverse the effects of chronic mild stress on behavior, the HPA axis, and proliferation of hippocampal precursor cell in vivo J. Ethnopharmacol. 144 2012 261 269
39. S.W. Park, S.K. Lee, J.M. Kim, J.S. Yoon, and Y.H. Kim Effects of quetiapine on the brain-derived neurotrophic factor expression in the hippocampus and neocortex of rats Neurosci. Lett. 402 2006 25 29
40. Z.W. Peng, Y.Y. Xue, H.N. Wang, H.H. Wang, F. Xue, F. Kuang, and et al. Sertraline promotes hippocampus-derived neural stem cells differentiating into neurons but not glia and attenuates LPS-induced cellular damage Prog. Neuro-Psychopharmacol. Biol. Psychiatry 36 2012 183 188
41. T.D. Perera, J.D. Coplan, S.H. Lisanby, C.M. Lipira, M. Arif, C. Carpio, and et al. Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates J. Neurosci. 27 2007 4894 4901
42. H.S. Phillips, J.M. Hains, G.R. Laramee, A. Rosenthal, and J.W. Winslow Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons Science 250 1990 290 294
43. A. Reif, A. Schmitt, S. Fritzen, S. Chourbaji, C. Bartsch, A. Urani, and et al. Differential effect of endothelial nitric oxide synthase (NOS-III) on the regulation of adult neurogenesis and behaviour Eur. J. Neurosci. 20 2004 885 895
44. S. Rossi, M. Hallett, P.M. Rossini, and A. Pascual-Leone Safety of TMSCG. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research Clin. Neurophysiol. 120 2009 2008 2039
45. L. Santarelli, M. Saxe, C. Gross, A. Surget, F. Battaglia, S. Dulawa, and et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants Science 301 2003 805 809
46. B.W. Scott, J.M. Wojtowicz, and W.M. Burnham Neurogenesis in the dentate gyrus of the rat following electroconvulsive shock seizures Exp. Neurol. 165 2000 231 236
47. C. Tomasetti, C. Dell'Aversano, F. Iasevoli, F. Marmo, and A. de Bartolomeis The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes Prog. Neuropsychopharmacol. Biol. Psychiatry 35 2011 184 197
48. W.Y. Tzeng, L.H. Chen, C.G. Cherng, Y.N. Tsai, and L. Yu Sex differences and the modulating effects of gonadal hormones on basal and the stressor-decreased newly proliferative cells and neuroblasts in dentate gyrus Psychoneuroendocrinology 42 2014 24 37
49. E. Ueyama, S. Ukai, A. Ogawa, M. Yamamoto, S. Kawaguchi, R. Ishii, and et al. Chronic repetitive transcranial magnetic stimulation increases hippocampal neurogenesis in rats Psychiatry Clin. Neurosci. 65 2011 77 81
50. P. Videbech, and B. Ravnkilde Hippocampal volume and depression: a meta-analysis of MRI studies Am. J. Psychiatry 161 2004 1957 1966
51. L. Wang, D. Peng, B. Xie, K. Jiang, and Y. Fang The extracellular signal-regulated kinase pathway may play an important role in mediating antidepressant-stimulated hippocampus neurogenesis in depression Med. Hypotheses 79 2012 87 91
52. Y. Wang, T. Chang, Y.C. Chen, R.G. Zhang, H.N. Wang, W.J. Wu, and et al. Quetiapine add-on therapy improves the depressive behaviors and hippocampal neurogenesis in fluoxetine treatment resistant depressive rats Behav. Brain Res. 253 2013 206 211
53. H.N. Wang, L. Wang, R.G. Zhang, Y.C. Chen, L. Liu, F. Gao, and et al. Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: the role of the endocannabinoid system J. Psychiatr. Res. 51 2014 79 87
54. L. Xiao, H. Xu, Y. Zhang, Z. Wei, J. He, W. Jiang, and et al. Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes Mol. Psychiatry 13 2008 697 708
55. H. Xu, H. Qing, W. Lu, D. Keegan, J.S. Richardson, J. Chlan-Fourney, and et al. Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus Neurosci. Lett. 321 2002 65 68
56. B. Yan, X. Bi, J. He, Y. Zhang, S. Thakur, H. Xu, and et al. Quetiapine attenuates spatial memory impairment and hippocampal neurodegeneration induced by bilateral common carotid artery occlusion in mice Life Sci. 81 2007 353 361